Yahoo Finance

ANORO(TM) ELLIPTA(TM) Approved as First Once-Daily Dual Bronchodilator for the Treatment of COPD in the US

LONDON, UK and SOUTH SAN FRANCISCO, CA--(Marketwired - Dec 18, 2013) - GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug ...
Yahoo Finance

Anoro(TM) Ellipta(R) Now Available in the US for Treatment of COPD

RESEARCH TRIANGLE PARK, NC and SOUTH SAN FRANCISCO, CA--(Marketwired - Apr 28, 2014) - GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that Anoro™ ...
FiercePharma

It's make-or-break time for GSK's new sales model as Anoro hits the U.S. market

GlaxoSmithKline ($GSK) isn't taking the launch of new COPD blockbuster hopeful Anoro Ellipta lightly; with market-leader Advair's dominance waning, it can't afford to ...
Yahoo Finance

Data Published on Anoro(R) Ellipta(R) Demonstrate Improved Lung Function Compared to Tiotropium

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA--(Marketwired - Oct 17, 2014) - Theravance, Inc. (NASDAQ: THRX) -- Respiratory Medicine has published positive results from a third lung function ...
McKnight's Long-Term Care News

FDA approves Anoro Ellipta

The U.S. Food and Drug Administration have approved GlaxoSmithKline’s Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive ...
Yahoo Finance

Anoro(R) (Umeclidinium/Vilanterol) Gains Marketing Authorisation in Europe for the Treatment of COPD

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA--(Marketwired - May 8, 2014) - GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the European ...
Reuters

GlaxoSmithKline lung drug Anoro approved in Europe

LONDON, May 8 (Reuters) - GlaxoSmithKline said on Thursday its new inhaled lung drug, Anoro, had been approved in Europe as a treatment for chronic lung disease, boosting its respiratory franchise. A ...
MM&M

Scotland’s NICE dislikes GSK’s Anoro

Scotland’s version of NICE, the Scottish Medicines Consortium (SMC), says two COPD drugs are not worth the Scottish National Health Service’s money. Among the drugs Regulatory Focus found on the SMC’s ...
PMLiVE

GSK clear to launch COPD hope Anoro in Europe

GlaxoSmithKline (GSK) is planning to launch its Anoro combination therapy for chronic obstructive pulmonary disorder (COPD) in the EU in the coming weeks following approval from the European ...
MarketWatch

GlaxoSmithKline: EMA recommends Anoro lung drug

LONDON--U.K. drug company GlaxoSmithKline PLC (GSK.LN) and Theravance Inc. THRX Thursday said a European Union agency recommended that their new treatment for lung disease be approved for sale. The ...
Reuters

GlaxoSmithKline's COPD drug Anoro receives European green light

LONDON (Reuters) - Anoro, a combination drug for chronic obstructive pulmonary disease (COPD) developed by GlaxoSmithKline and Theravance, has received the green light from European regulators, the ...